MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinsonism"

  • 2016 International Congress

    Recognition of parkinsonism in African Americans in a community-based sample

    D.A. Hall, B. Ouyang, J.M. Shulman, L.M. Shulman, D.A. Bennett, L.L. Barnes (Chicago, IL, USA)

    Objective: To investigate recognition of parkinsonism in African Americans (AA) in a community-based sample in Chicago. Background: Prior studies suggest that the manifestation of parkinsonism…
  • 2016 International Congress

    Quality of life of Parkinson’s disease patients in a tertiary hospital in Hong Kong

    H.F. Chan, Y.F. Cheung, D.K.W. Chau, T. Fung, I. Chan, W.C. Fong (Hong Kong, Hong Kong)

    Objective: 1. To evaluate the quality of life (QoL) profile of Parkinson's disease (PD) patients in a multidisciplinary clinic in a tertiary hospital in Hong…
  • 2016 International Congress

    My PD Journey: Experiences reported by people with Parkinson’s disease in several European countries – A quantitative and qualitative study

    A. Schrag, O. Rascol, R. Merritt, S. Hotham, G. Bartl, L. Graham, On behalf of the European Parkinson's Disease Association (EPDA) and the Movement Disorder Society- European Section European Section (London, United Kingdom)

    Objective: To document experience of service provision by people with Parkinson's disease (PD) care in Europe. Background: Developed by the EPDA, My PD Journey is…
  • 2016 International Congress

    Survey of telemedicine use among MDS members

    A. Hassan, E.R. Dorsey, E. Cubo, C.G. Goetz, B.R. Bloem, M. Guttman, S.L. Heath, M. Katz, M. Spinder, C.M. Tanner, Z. Mari, A. Pantelyat, J.A. Bajwa, N.B. Galifianakis, E.M. Gatto (Rochester, MN, USA)

    Objective: To evaluate telemedicine use amongst global members of the International Parkinson and Movement Disorders Society (MDS). Background: The current utilization of telemedicine by healthcare…
  • 2016 International Congress

    A novel homozygous DJ1 mutation causes parkinsonism and ALS in a Turkish family

    H.A. Hanagasi, A. Giri, G. Guven, B. Bilgic, A.K. Hauser, M. Emre, P. Heutink, N. Basak, T. Gasser, J. Simón-Sánchez, E. Lohmann (Istanbul, Turkey)

    Objective: To present the clinical features and genetic findings of a Turkish family a new DJ1 mutation and presenting with early-onset levodopa responsive parkinsonism and…
  • 2016 International Congress

    Gene network driven probable drug target identification: An in-silico study on Parkinson’s disease

    H.N. Singh, J. Pani, K.G. Singh, V. Swarup (Gautam Budh Nagar, India)

    Objective: Identification of probable drug targets. Background: Parkinson's disease, a motor system disorder, which manifests due to the loss of brain cells that produces dopamine.…
  • 2016 International Congress

    Parkinson’s disease-associated Miro1 mutants cause mitochondrial dysfunction

    D. Grossmann, D. Scheibner, J. Fitzgerald, W. Mätzler, L. Burbulla, R. Krüger (Belvaux, Luxembourg)

    Objective: In the present study we dissected the role of the first PD-associated mutations in RhoT1, the gene encoding for Miro1. Background: Commonly involved pathogenic…
  • 2016 International Congress

    Speed and severity of toxicity induced by pre-formed α-synuclein fibrils in rat brain is enhanced by α-synuclein overexpression

    P. Thakur, L. Breger, B. Mattsson, K. Luk, V.M. Lee, J. Trojanowski, A. Björklund (Lund, Sweden)

    Objective: To develop a physiologically relevant model of PD. Background: Intracerebral injection of pre-formed α-synuclein fibrils has emerged as an interesting tool to induce PD-like…
  • 2016 International Congress

    Dysregulated macroautophagy and mitochondrial dynamics in PD with glucocerebrosidase mutations

    S.H. Kuo, H. Li, A. Ham, M.M. Cheng, Y. Quan, D. Sulzer, G. Tang (New York, NY, USA)

    Objective: To investigate markers of macroautophagy and mitochondrial dynamics in fibroblasts and postmortem brain of Parkinson's disease (PD) patients with glucoerebrosidase (GBA1) mutations and controls.…
  • 2016 International Congress

    Diffusion tensor imaging (DTI) within the primate caudate nucleus marks dopaminergic (DA) and serotonergic (5-HT) lesions

    S. Thobois, E. Météreau, M. Beaudoin-Gobert, S. Duperrier, L. Tremblay, V. Sgambato-Faure (Bron, France)

    Objective: To determine the best diffusion tensor imaging markers of dopaminergic and serotonergic lesions in the non-human primate. Background: DTI has received particular interest to…
  • « Previous Page
  • 1
  • …
  • 351
  • 352
  • 353
  • 354
  • 355
  • …
  • 405
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley